BIIB Biogen Inc.
Healthcare$193.76+2.26%ClosedMarket Cap: $28.61B
As of 2026-05-25
Insider Statistics (Q2 2026)
Acquisitions
1
Dispositions
2
Buy/Sell Ratio
0.50
Net Shares
-54
Shares Acquired
181
Shares Disposed
235
Total Bought ($)
$0.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue May 05 | Keeney Adam | officer: Head of Corporate Development | Sell | 939 | $0.00 | 6,820 |
| Tue May 05 | Keeney Adam | officer: Head of Corporate Development | Sell | 455 | $187.06 | 6,365 |
| Fri Apr 03 | Godbout Sean | officer: Chief Accounting Officer | Sell | 181 | $0.00 | 1,396 |
| Fri Apr 03 | Godbout Sean | officer: Chief Accounting Officer | Sell | 54 | $183.78 | 1,342 |
| Tue Feb 17 | Viehbacher Christopher | director, officer: President and CEO | Sell | 38,015 | $0.00 | 38,015 |
| Tue Feb 17 | Singhal Priya | officer: Head of Development | Sell | 10,560 | $0.00 | 10,560 |
| Tue Feb 17 | Murphy Nicole | officer: Head of Pharm Ops and Tech | Buy | 3 | $195.04 | 19,611 |
| Tue Feb 17 | Murphy Nicole | officer: Head of Pharm Ops and Tech | Sell | 10,560 | $0.00 | 10,560 |
| Tue Feb 17 | Kramer Robin | officer: Chief Financial Officer | Sell | 8,450 | $0.00 | 8,450 |
| Tue Feb 17 | Keeney Adam | officer: Head of Corporate Development | Sell | 8,025 | $0.00 | 8,025 |
| Tue Feb 17 | Izzar Rachid | officer: Head of Global Product Strat. | Sell | 7,390 | $0.00 | 7,390 |
| Tue Feb 17 | Grogan Jane | officer: Head of Research | Sell | 8,450 | $0.00 | 8,450 |
| Tue Feb 17 | Gregory Ginger | officer: EVP, Human Resources | Sell | 8,025 | $0.00 | 8,025 |
| Tue Feb 17 | Godbout Sean | officer: Chief Accounting Officer | Sell | 1,800 | $0.00 | 1,800 |